FAK Inhibition Attenuates Corneal Fibroblast Differentiation In Vitro

Corneal fibrosis (or scarring) occurs in response to ocular trauma or infection, and by reducing corneal transparency, it can lead to visual impairment and blindness. Studies highlight important roles for transforming growth factor (TGF)-β1 and -β3 as modulators in corneal wound healing and fibrosis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vincent Yeung, Sriniwas Sriram, Jennifer A. Tran, Xiaoqing Guo, Audrey E. K. Hutcheon, James D. Zieske, Dimitrios Karamichos, Joseph B. Ciolino
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/392e63b66603462983e9326a3b179321
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:392e63b66603462983e9326a3b179321
record_format dspace
spelling oai:doaj.org-article:392e63b66603462983e9326a3b1793212021-11-25T16:53:47ZFAK Inhibition Attenuates Corneal Fibroblast Differentiation In Vitro10.3390/biom111116822218-273Xhttps://doaj.org/article/392e63b66603462983e9326a3b1793212021-11-01T00:00:00Zhttps://www.mdpi.com/2218-273X/11/11/1682https://doaj.org/toc/2218-273XCorneal fibrosis (or scarring) occurs in response to ocular trauma or infection, and by reducing corneal transparency, it can lead to visual impairment and blindness. Studies highlight important roles for transforming growth factor (TGF)-β1 and -β3 as modulators in corneal wound healing and fibrosis, leading to increased extracellular matrix (ECM) components and expression of α-smooth muscle actin (αSMA), a myofibroblast marker. In this study, human corneal fibroblasts (hCF) were cultured as a monolayer culture (2D) or on poly-transwell membranes to generate corneal stromal constructs (3D) that were treated with TGF-β1, TGF-β3, or TGF-β1 + FAK inhibitor (FAKi). Results show that hCF 3D constructs treated with TGF-β1 or TGF-β3 impart distinct effects on genes involved in wound healing and fibrosis—<i>ITGAV</i>, <i>ITGB1</i>, <i>SRC</i> and <i>ACTA2</i>. Notably, in the 3D construct model, TGF-β1 enhanced αSMA and focal adhesion kinase (FAK) protein expression, whereas TGF-β3 did not. In addition, in both the hCF 2D cell and 3D construct models, we found that TGF-β1 + FAKi attenuated TGF-β1-mediated myofibroblast differentiation, as shown by abrogated αSMA expression. This study concludes that FAK signaling is important for the onset of TGF-β1-mediated myofibroblast differentiation, and FAK inhibition may provide a novel beneficial therapeutic avenue to reduce corneal scarring.Vincent YeungSriniwas SriramJennifer A. TranXiaoqing GuoAudrey E. K. HutcheonJames D. ZieskeDimitrios KaramichosJoseph B. CiolinoMDPI AGarticle3D cell culturecorneal scarringextracellular matrix (ECM)focal adhesion kinase (FAK)α-smooth muscle actin (αSMA)MicrobiologyQR1-502ENBiomolecules, Vol 11, Iss 1682, p 1682 (2021)
institution DOAJ
collection DOAJ
language EN
topic 3D cell culture
corneal scarring
extracellular matrix (ECM)
focal adhesion kinase (FAK)
α-smooth muscle actin (αSMA)
Microbiology
QR1-502
spellingShingle 3D cell culture
corneal scarring
extracellular matrix (ECM)
focal adhesion kinase (FAK)
α-smooth muscle actin (αSMA)
Microbiology
QR1-502
Vincent Yeung
Sriniwas Sriram
Jennifer A. Tran
Xiaoqing Guo
Audrey E. K. Hutcheon
James D. Zieske
Dimitrios Karamichos
Joseph B. Ciolino
FAK Inhibition Attenuates Corneal Fibroblast Differentiation In Vitro
description Corneal fibrosis (or scarring) occurs in response to ocular trauma or infection, and by reducing corneal transparency, it can lead to visual impairment and blindness. Studies highlight important roles for transforming growth factor (TGF)-β1 and -β3 as modulators in corneal wound healing and fibrosis, leading to increased extracellular matrix (ECM) components and expression of α-smooth muscle actin (αSMA), a myofibroblast marker. In this study, human corneal fibroblasts (hCF) were cultured as a monolayer culture (2D) or on poly-transwell membranes to generate corneal stromal constructs (3D) that were treated with TGF-β1, TGF-β3, or TGF-β1 + FAK inhibitor (FAKi). Results show that hCF 3D constructs treated with TGF-β1 or TGF-β3 impart distinct effects on genes involved in wound healing and fibrosis—<i>ITGAV</i>, <i>ITGB1</i>, <i>SRC</i> and <i>ACTA2</i>. Notably, in the 3D construct model, TGF-β1 enhanced αSMA and focal adhesion kinase (FAK) protein expression, whereas TGF-β3 did not. In addition, in both the hCF 2D cell and 3D construct models, we found that TGF-β1 + FAKi attenuated TGF-β1-mediated myofibroblast differentiation, as shown by abrogated αSMA expression. This study concludes that FAK signaling is important for the onset of TGF-β1-mediated myofibroblast differentiation, and FAK inhibition may provide a novel beneficial therapeutic avenue to reduce corneal scarring.
format article
author Vincent Yeung
Sriniwas Sriram
Jennifer A. Tran
Xiaoqing Guo
Audrey E. K. Hutcheon
James D. Zieske
Dimitrios Karamichos
Joseph B. Ciolino
author_facet Vincent Yeung
Sriniwas Sriram
Jennifer A. Tran
Xiaoqing Guo
Audrey E. K. Hutcheon
James D. Zieske
Dimitrios Karamichos
Joseph B. Ciolino
author_sort Vincent Yeung
title FAK Inhibition Attenuates Corneal Fibroblast Differentiation In Vitro
title_short FAK Inhibition Attenuates Corneal Fibroblast Differentiation In Vitro
title_full FAK Inhibition Attenuates Corneal Fibroblast Differentiation In Vitro
title_fullStr FAK Inhibition Attenuates Corneal Fibroblast Differentiation In Vitro
title_full_unstemmed FAK Inhibition Attenuates Corneal Fibroblast Differentiation In Vitro
title_sort fak inhibition attenuates corneal fibroblast differentiation in vitro
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/392e63b66603462983e9326a3b179321
work_keys_str_mv AT vincentyeung fakinhibitionattenuatescornealfibroblastdifferentiationinvitro
AT sriniwassriram fakinhibitionattenuatescornealfibroblastdifferentiationinvitro
AT jenniferatran fakinhibitionattenuatescornealfibroblastdifferentiationinvitro
AT xiaoqingguo fakinhibitionattenuatescornealfibroblastdifferentiationinvitro
AT audreyekhutcheon fakinhibitionattenuatescornealfibroblastdifferentiationinvitro
AT jamesdzieske fakinhibitionattenuatescornealfibroblastdifferentiationinvitro
AT dimitrioskaramichos fakinhibitionattenuatescornealfibroblastdifferentiationinvitro
AT josephbciolino fakinhibitionattenuatescornealfibroblastdifferentiationinvitro
_version_ 1718412887069818880